London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
My view is that this is worthy of an RNS if the likely sales are in excess of Ā£20m (which it is!). Watch this space. Still not expecting a July sales update given last sales update was 3 weeks ago... September interims are going to be so tasty
with the 2000 patient trial using Novacyt's testing system update around two weeks past , investors on share board posted ,hours before ncyt updated
be watching to see , will they release a rns later
Actually never mind, they have just replied now, but asked me for my location to put me in touch with the 'relevant sales manager' to handle the query.
Oh they told you that it's not for sale on chat?
Asked PD through email last night if the HT version was ready for purchase. Still waiting on reply.
I guess AZN have stockpiled the whole run so far then?
Either way, huge news to be confirmed shortly, VERY promising.
I was a big advocate of AZ buying out NCYT a couple of months ago and can see that as a distinct possibility now. It has to have been discussed. Maybe even a probability. We'll see....
if this is true and ncyt update with a rns
then be interesting to see how share price moves i
would not want to be short if that news is released
fail41 thats not strictly true. It hasn't "publicly" been released for sale but has been launched and is being sold. All stock is currently going to AstraZeneca as this was designed and manufactured for them
The new test has not been launched yet. It is not available to buy. This has been confirmed by a member of their team on the online chat facility. The launch will come soon and it will be massive if the test is for AZ. This is going to be mega!
Goliath. , thinking decent move up seen again today ,buys starting to build already
the short is really going to struggle buying 600,000 back which they will have to do soon.
Who on earth is going to give them shares at this level with the sales , profit and cash coning in.
It is going to get really explosive - very soon now
hoping a rns from them
buying building again , will another strong afternoon be seen again
No way, so blade caught them out yesterday. They weren't planning on letting the market know the dept of their involvement yet. Brilliant to see them respond. Must have been waiting to before doing a big market update so what's the reason for the holdup?
Some award or trial or something finishing so they can put out an RNS in style I guess.
Join The Dots
Maybe this can explain the rush hour to buy Novacyt yesterday.
I just see 3.63 order placed in France, is possible a blue finish again today
Very positive tweet.
I do wish people wouldn't reply with silly memes to primer design's tweets though. It trivialises a very serious company doing very important work!
Yep it is, but it says to me without Randox around, NCYT are now the backbone of all PCR testing in the UK. I think that tender when it comes will reflect that.
Woodaldo, this is part of 5 Pillar agreement back in April?
Also, Astra will have 200Mil Grant from The Government
All looks good for us now
https://twitter.com/PrimerdesignLtd/status/1291279891015569408
#Novacyt is proud to contribute with our genesigĀ® COVID-19 test to the largest network of diagnostic testing capabilities in British history. This is covering a total of 3 mega labs, 71 drive-through sites and 236 mobile testing units https://cam.ac.uk/news/how-science-and-innovation-are-helping-tackle-covid-19-testin
#NCYT #COVID-19